Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1967452 | 0.84 | PPARG (0.42) | MEN1KMT2ATSHRALDH1A1HDAC2 | |
| SCHEMBL3710006 | 0.82 | TSHR (0.34) | MEN1KMT2ATSHRALDH1A1HDAC2 | |
| SCHEMBL29022994 | 0.81 | TSHR (0.42) | TSHRALDH1A1HDAC2CA1CA2 | |
| SCHEMBL6862113 | 0.81 | HDAC2 (0.34) | MEN1KMT2AHDAC2TDP1 | |
| SCHEMBL3262845 | 0.80 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRTDP1 | |
| SCHEMBL21930547 | 0.80 | TDP1 (0.34) | TSHRHDAC2TDP1 | |
| SCHEMBL7774736 | 0.80 | TSHR (0.37) | MEN1KMT2ASMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL21930549 | 0.80 | TDP1 (0.34) | TSHRHDAC2TDP1 | |
| SCHEMBL7772586 | 0.80 | TSHR (0.37) | MEN1KMT2ASMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL7708142 | 0.79 | TDP1 (0.36) | SMN1; SMN2HDAC2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-6916851-B2 | Microbiocides; skin disorders; aging resistance | UNILEVER HOME & PERSONAL CARE USA, A DIVISION OF CONOPCO, INC. (US) | 2005-07-12 | — | — | US | disclosed |
| US-20040018948-A1 | Skin care cosmetic methods of sebum control using carboxyalkylates of branched alcohols and/or alkoxylates thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-01-29 | — | — | US | disclosed |
| WO-2004006883-A1 | SKIN CARE COSMETIC COMPOSITIONS CONTAINING CARBOXYALKYLATES OF BRANCHED ALCOHOLS AND/OR ALKOXYLATES THEREOF | UNILEVER PLC (GB) | 2004-01-22 | — | — | WO | disclosed |
| US-20040013630-A1 | Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-01-22 | — | — | US | disclosed |
| US-20040013631-A1 | Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO | 2004-01-22 | — | — | US | disclosed |
| EP-0459369-B1 | Fluorine-containing polymer for paints and paint composition containing the polymer | DAIKIN IND LTD (JP) | 1995-03-15 | — | — | EP | disclosed |
| US-5171804-A | Electrodeposition coating | DAIKIN INDUSTRIES, LTD. (JP) | 1992-12-15 | — | — | US | disclosed |
| EP-0459369-A1 | Fluorine-containing polymer for paints and paint composition containing the polymer | DAIKIN INDUSTRIES, LTD. (JP) | 1991-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018948-A1 | Skin care cosmetic methods of sebum control using carboxyalkylates of branched alcohols and/or alkoxylates thereof | CUTA, SCD5, LIPE | MEN1 4545/4885KMT2A 4397/4885SMN1; SMN2 4077/4885 |
| US-20040013630-A1 | Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof | CUTA, SCD5, LIPE | MEN1 4496/4885KMT2A 4287/4885SMN1; SMN2 3887/4885 |
| US-20040013631-A1 | Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof | CUTA, YAP1, EBP | MEN1 4634/4885KMT2A 3910/4885SMN1; SMN2 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.